Nanotrap® Microbiome Particles | Ceres Nanosciences, Inc.

Nanotrap Microbiome Particles

Labs around the world are using Nanotrap® Microbiome Particles to capture and concentrate microbes from samples in order to improve detection of those microbes.

Nanotrap Microbiome A Particles capture and concentrate a wide range of microbes, including influenza A virus, influenza B virus, respiratory syncytial virus, coronavirus 229E, coronavirus OC43, SARS-CoV-2, Zika virus, Chikungunya virus, dengue virus, pepper mild mottle virus, hepatitis A virus, monkeypox virus, norovirus GII, Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Measles morbillivirus, Escherichia coli, Salmonella enterica, Campylobacter jejuni, Listeria monocytogenes, and Clostridioides difficile.

Nanotrap Microbiome B Particles capture and concentrate a wide range of microbes, including Escherichia coli, Salmonella enterica, Campylobacter jejuni, Listeria monocytogenes, Clostridioides difficile, Candida auris, Cryptosporidium parvum, and Giardia lamblia.

There is a growing list of microbes that have been captured and concentrated with the Nanotrap Microbiome Particles. If you don’t see your microbe of interest on this list, contact us to discuss your application.

Capture and concentrate low abundance microbes - Nanotrap Particles utilize affinity capture to attract and bind low abundance microbes. Nanotrap Particles do not utilize antibodies or other biomolecules as affinity molecules which means extended room temperature stability.

Compatible with your workflow – Compatible with qPCR, dPCR, ddPCR, sequencing, or immunoassay analysis methods.

Successfully utilized in high-complexity and point-of-care RT-PCR assays with FDA Emergency Use Authorization for COVID-19.

Save hands-on time - Workflow enables rapid and simple automated or manual methods for preparing environmental water samples for nucleic acid extraction, without filtration or centrifugation.